Impaired dexamethasone-related increase of anticoagulants is associated with the development of osteonecrosis in childhood acute lymphoblastic leukemia

Haematologica

Volumn 93, Issue 10, 2008, Pages 1570-1574

  Te Winkel, Mariel L ^a   Appel, Inge M ^a   Pieters, Rob ^a   Van Den Heuvel Eibrink, Marry M ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Acute lymphoblastic leukemia; Antithrombin; Hypercoagulability; Osteonecrosis; Protein S

Indexed keywords

ANTITHROMBIN; DEXAMETHASONE; PROTEIN S;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BONE NECROSIS; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIBRINOLYSIS; HUMAN; HYPERCOAGULABILITY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS;

ADOLESCENT; ANTICOAGULANTS; CHILD; CHILD, PRESCHOOL; DEXAMETHASONE; FEMALE; HUMANS; MALE; OSTEONECROSIS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 54349093739     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.12956     Document Type: Article

References (24)

1. Glimcher MJ, Kenzora JE. The biology of osteonecrosis of the human femoral head and its clinical implications: II. The pathological changes in the femoral head as an organ and in the hip joint. Clin Orthop Relat Res 1979:283-312.
2. Jones JP Jr. Intravascular coagulation and osteonecrosis. Clin Orthop Relat Res 1992:41-53.
3. Kechli AM, Wilimas JA, Pui CH, Park VM, Tonkel S, Deitcher SR. Factor V Leiden and other hypercoagulable state mutations are not associated with osteonecrosis during or after treatment for pediatric malignancy. J Pediatr 1999;134:310-4.
4. van Beek RD, Bezemer DD, Meijerink JP, de Muinck Keizer-Schrama SM, Haas OA, Te Winkel L, et al. Repeats in the kringle IV encoding domains in the Apo(a) gene and serum lipoprotein(a) level do not contribute to the risk for avascular necrosis of the bone (AVN) in pediatric acute lymphoblastic leukemia. Leukemia 2006;20:879-80.
5. Hanada T, Horigome Y, Inudoh M, Takita H. Osteonecrosis of vertebrae in a child with acute lymphocytic leukaemia during L-asparaginase therapy. Eur J Pediatr 1989;149:162-3.
6. Appel IM, Hop WC, Pieters R. Changes in hypercoagulability by asparaginase: a randomized study between two asparaginases. Blood Coagul Fibrinolysis 2006;17:139-46.
7. Athale UH, Chan AK. Thrombosis in children with acute lymphoblastic leukemia. Part II. Pathogenesis of thrombosis in children with acute lymphoblastic leukemia: effects of the disease and therapy. Thromb Res 2003;111:199-212.
8. Caruso V, Iacoviello L, Di Castelnuovo A, Storti S, Mariani G, de Gaetano G, et al. Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients. Blood 2006; 108:2216-22.
9. Mitchell LG, Halton JM, Vegh PA, Barr RD, Venneri T, Pai KM, et al. Effect of disease and chemotherapy on hemostasis in children with acute lymphoid leukemia. Am J Pediatr Hematol Oncol 1994;16:120-6.
10. Nowak-Gottl U, Ahlke E, Fleischhack G, Schwabe D, Schobess R, Schumann C, et al. Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration. Blood 2003; 101:2529-33.
11. Szepesi K, Posan E, Harsfalvi J, Ajzner E, Szucs G, Gaspar L, et al. The most severe forms of Perthes' disease associated with the homozygous factor V Leiden mutation. J Bone Joint Surg Br 2004;86:426-9.
12. Balasa VV, Gruppo RA, Glueck CJ, Wang P, Roy DR, Wall EJ, et al. Legg-Calve-Perthes disease and thrombophilia. J Bone Joint Surg Am 2004; 86:2642-7.
13. Glueck CJ, Fontaine RN, Gruppo R, Stroop D, Sieve-Smith L, Tracy T, et al. The plasminogen activator inhibitor-1 gene, hypofibrinolysis, and osteonecrosis. Clin Orthop Relat Res 1999:133-46.
14. French D, Hamilton LH, Mattano LA Jr, Sather HN, Devidas M, Nachman JB, et al. A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood 2008;111:4496-9.
15. Veerman AJ, Hahlen K, Kamps WA, Van Leeuwen EF, De Vaan GA, Solbu G, et al. High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group. J Clin Oncol 1996;14:911-8.
16. van der Sluis IM, van den Heuvel-Eibrink MM, Hahlen K, Krenning EP, de Muinck Keizer-Schrama SM. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia. J Pediatr 2002; 141:204-10.
17. Ribeiro RC, Fletcher BD, Kennedy W, Harrison PL, Neel MD, Kaste SC, et al. Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma. Leukemia 2001;15:891-7.
18. Robinson HJ Jr, Hartleben PD, Lund G, Schreiman J. Evaluation of magnetic resonance imaging in the diagnosis of osteonecrosis of the femoral head. Accuracy compared with radiographs, core biopsy, and intraosseous pressure measurements. J Bone Joint Surg Am 1989; 71:650-63.
19. Clauss A. [Rapid physiological coagulation method in determination of fibrinogen.]. Acta Haematol 1957; 17:237-46.
20. Holvoet P, de Boer A, Verstreken M, Collen D. An enzyme-linked immunosorbent assay (ELISA) for the measurement of plasmin-alpha 2-antiplasmin complex in human plasma - application to the detection of in vivo activation of the fibrinolytic system. Thromb Haemost 1986; 56:124-7.
21. Ries M, Klinge J, Rauch R. Age-related reference values for activation markers of the coagulation and fibrinolytic systems in children. Thromb Res 1997;85:341-4.
22. Arico M, Boccalatte MF, Silvestri D, Barisone E, Messina C, Chiesa R, et al. Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia. Haematologica 2003;88: 747-53.
23. Nachman JB. Adolescents with acute lymphoblastic leukemia: a new "age". Rev Clin Exp Hematol 2003; 7:261-9.
24. Appel IM, van Kessel-Bakvis C, Stigter R, Pieters R. Influence of two different regimens of concomitant treatment with asparaginase and dexamethasone on hemostasis in childhood acute lymphoblastic leukemia. Leukemia 2007;21:2377-80.